Glenmark Pharmaceuticals (GLENMARK.NSE) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
1.69
8.32
14.95
21.57

Details

Expected EPS
N/A
Actual EPS
21.5742438644
Surprise EPS
21.57
Surprise Percent
+∞%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 21.5742438644 per share for Q4 2025.

0 Comments

Share your thoughts